RxDoctor Payments Data

Stephanie Judy

Family · Wilmington, DENPI 1699143404

Payments from drug & device makers

$1,196in general payments, 2019–2025

Across 71 payments — averaging $16.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$262
  • Biohaven Pharmaceuticals, Inc.$129
  • AbbVie$115
  • Johnson & Johnson$80
  • Boehringer Ingelheim$65
  • Alkermes, Inc.$59
  • plus $487 from 21 others

What the payments were for

  • Food & beverage$1,18599%
  • Education$121%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,196 in reported general payments places this provider in the 65th percentile of 523 family providers in Delaware.

See all family providers in Delaware

Most prescribed under Part D

DrugClaimsCost to plans & patients
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst37$482
Doxycycline Hyclate25$190
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav23$174
Ciprofloxacin Hcl21$82
Cephalexin21$61
Amoxicillin16$39

Paid to pharmacies, not to this prescriber.

Other family in Wilmington

See the full list for Delaware

Where these figures come from

Is this you, or does something look wrong? →